Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications (Q34200319)

31 July 2017

1 reference

title

Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications (English)

1 reference

left ventricular hypertrophy

31 July 2017

0 references

0 references

1 reference

1 reference

Richard E Katholi

1

1 reference

PubMed ID

21755036

31 July 2017

Daniel M Couri

series ordinal

2

1 reference

PubMed ID

21755036

31 July 2017

language of work or name

1 reference

30 June 2011

1 reference

International Journal of Hypertension

31 July 2017

1 reference

31 July 2017

2011

1 reference

31 July 2017

495349

1 reference

Creative Commons Attribution 3.0 Unported

31 July 2017

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Renal nerves in the maintenance of hypertension: a potential therapeutic target.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Statins: a perspective for left ventricular hypertrophy treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Sudden death in young athletes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Assessment of left ventricular mass by cardiovascular magnetic resonance.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Diagnosis and Treatment of Systolic Heart Failure in the Elderly

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Carvedilol in the treatment of hypertension--a review of the clinical data base

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Left ventricular hypertrophy in hypertensive patients is associated with abnormal rate adaptation of QT interval.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Role of oxidative stress in transition of hypertrophy to heart failure

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Cardiac hypertrophy and failure in hypertension

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Sex differences in the antagonism of swim stress-induced analgesia: effects of gonadectomy and estrogen replacement

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

The cardiac renin-angiotensin-aldosterone system and hypertensive cardiac hypertrophy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Does physical activity lower blood pressure: a critical review of the clinical trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Electrophysiological effects of magnesium on cells in the canine sinus node and false tendon

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Echocardiographic assessment of left ventricular structure and diastolic filling in elderly subjects with borderline isolated systolic hypertension (the Framingham Heart Study)

28 July 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Association between cardiovascular outcomes and antihypertensive drug treatment in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Ethnicity and left ventricular diastolic function in hypertension an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Left ventricular changes in isolated office hypertension: a blood pressure-matched comparison with normotension and sustained hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Physiologic left ventricular cavity dilatation in elite athletes.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Prognostic significance of left ventricular mass change during treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Response of hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Diuretic therapy for hypertension and the risk of primary cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension and their influences on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Renal sympathetic-nerve ablation for uncontrolled hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

The progression from hypertension to congestive heart failure

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Left ventricular hypertrophy has a greater impact on survival in women than in men

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132610

Impact of left ventricular structure on the incidence of hypertension. The Framingham Heart Study

28 October 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F495349

Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment

21 January 2018

1 reference

12 December 2020

Left ventricular hypertrophy in athletes

1 reference

12 December 2020

Left ventricular hypertrophy in patients with renal artery stenosis

1 reference

12 December 2020

Impact of the metabolic syndrome on total arterial compliance in essential hypertension patients

1 reference

12 December 2020

Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)

1 reference

12 December 2020

Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate

1 reference

12 December 2020

Enalapril-induced regression of hypertensive left ventricular hypertrophy, regional ischemia, and microvascular angina

1 reference

12 December 2020

Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men

1 reference

12 December 2020

Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients

1 reference

12 December 2020

Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy

1 reference

12 December 2020

Hypertensive heart disease syndrome in women in a cardiology practice

1 reference

12 December 2020

Comparison of target organ damage in renovascular and essential hypertension

1 reference

12 December 2020

17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X

1 reference

12 December 2020

Prevalence and natural history of electrocardiographic left ventricular hypertrophy

1 reference

12 December 2020

Carvedilol prevents severe hypertensive cardiomyopathy and remodeling

1 reference

12 December 2020

Decreased adrenergic response in hypertensive patients without left ventricular hypertrophy

1 reference

12 December 2020

Left ventricular mass reduction during salt depletion in arterial hypertension

1 reference

12 December 2020

ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption

1 reference

12 December 2020

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study

1 reference

12 December 2020

Identifiers

DOI

10.4061/2011/495349

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

PubMed ID

21755036